While many researchers are focused on the Tregs-associated suppression and the powerful force of IL-10, successful immunotherapies will only be developed for schistosomiasis if we have a broader view and deeper understanding of the mechanism of T-cell-mediated liver immunopathology. This evidence concerns the gene IL10 and schistosomiasis.